姓名：刘加军 性别：男 职称：教授
学院：附属第三医院 最后学历：博士
主要研究方向：造血干细胞移植及基因治疗在白血病中的应用 ；白血病细胞凋亡信号转导机制及血液肿瘤的分子靶向治疗；新型抗肿瘤、抗白血病药物的分子作用靶点筛选。
社会兼职:
1. SCI 杂志 Anti-Cancer Drugs 编委（ 2009 年 IF:2.23 ）。
2. 教育部“中国科技论文在线”特邀评审专家。
3. British Journal of Hematology 、 International Journal of Cancer 、 Oncology 等多种杂志审稿人。
4. 国家自然科学基金及广东省自然科学基金评审专家。
5. 欧洲肿瘤协会抗癌分会国际会员。
6. 广东省中西医结合学会常委。
7. 广州市抗癌协会血液肿瘤分会常委。
医疗专长:
从事内科血液学临床医疗及科研工作 20 余年。 血液病的造血干细胞移 植治疗，白血病治疗方案及个体化治疗原则的选择，各种原因不明的发热、贫血、出血性疾病、 骨髓瘤及淋巴瘤等血液病的治疗。
获奖情况:
1.2004 年荣获中山大学附属三院优秀中青年医师奖，是中山大学“千百十人才工程”培养对象。
2. 2006-2007 年以来被美国 Who's who in The Medicine and Healthcare （世界医学与健康护理名人录）收录。
3. 2006 年被评为教育部“新世纪优秀人才”。
4. 2008 及 2009 年教育部“科技论文在线”优秀通讯评审专家。
论 著:
截至到目前为止，在国内外核心期刊发表学术论文 50 余篇 ( 第一作者 ), 其中 SCI 收录 20 余篇。
以第一或通讯作者发表的主要代表论文（均为 SCI 收录）有：
1. Antibody directed lentiviral mediated double suicide gene therapy in MUC-1 positive leukemia in vitro and in vivo. Cell Transplant 2011(In Press)
2. PPARγ Agonist Suppresses TLR4 Expression and TNF-α Production in LPS Stimulated Monocyte Leukemia Cells. Cell Biochem Biophys . 2010 Nov 23. [Epub ahead of print] ( 通讯作者 ) 。
3. Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro. Annals of Hematology 2010; 89(5):1089–1097. （通讯作者）
4. Down-Regulation of Telomerase Activity and Activation of Caspase Are Responsible for Tanshinone I-Induced Apoptosis in Monocyte Leukemia Cells. International Journal of Molecular Sciences 2010; 11(5): 2267-2280.
5. Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocyti leukemia cells via downregulation of XIAP. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2009; 24(5): 623-632.
6. Peroxisome Proliferator-Activated Receptor γ (PPAR-γ) Agonist Rosiglitazone (RGZ) Inhibits HL-60 Cell Growth by Induction of Apoptosis. Lab Medicine 2009; 40(5):297-302.
7. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis. Oncology Reports 2009; 21(3): 1075-1081.
8. Peroxisome Proliferator-Activated Receptor-g Agonist Rosiglitazone–Induced Apoptosis in Leukemia K562 Cells and Its Mechanisms of Action. International Journal of Toxicology 2009; 28(2):123-131.
9. Ponicidin Inhibits Monocytic Leukemia Cell Growth by Induction of Apoptosis. International Journal of Molecular Sciences 2008 ; 9(11) : 2265-2277.
10. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro. Annals of Hematology 2007;86 (3):173-183.
11. Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. Journal of Biomedical Science 2006; 13(12):813–823.
12. Antiproliferation Effects of Oridonin on HPB-ALL Cells and Its Mechanisms of Action. American Journal of Hematology 2006; 81(2):86–94.
13. Ponicidin, an Ent-Kaurane Diterpenoid Derived from a Constituent of the Herbal Supplement PC-SPES, Rabdosia rubescens , Induces Apoptosis by Activation of Caspase-3 and Mitochondrial Events in Lung Cancer Cells In Vitro. Cancer Investigation 2006; 24(2):136–148.
14. Expression of survivin and bax/bcl -2 in peroxisome proliferator activated receptor-{gamma} ligands induces apoptosis on human myeloid leukemia cells in vitro . Annals of Oncology 2005; 16(3):455-459.
15. Peroxisome proliferator activated receptor- ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemotherapy and Pharmacology 2005;56(4):400-408.
16. Oridonin-induced apoptosis in leukemia K562 cells and its mechanism. Neoplasma 2005;52 (3):225-230.
17. Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro . Oncology Reports 2005; 13 (4):653-657.
18. Apoptotic effect of oridonin on NB4 cells and its mechanism. Leukemia & Lymphoma 2005; 46 (4): 593-597.
19. Antiproliferation effects of oridonin on HL-60 cells. Annals of Hematology 2004; 83(11):691-695.
20. Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action. Journal of International Medical Research 2004; 32 (6):617-625.
21 . Oridonin Inhibit Cell Growth by Induction of Apoptosis on Human Carcinoma BEL7402 Cells. Hepatology Research . 2006;35(2)104-110.
22 . Oridonin-induced apoptosis of Jurkat cells and its mechanism. Comparative Pathology. 2004;13(2): 65-69.
专 著:参编：《临床症状与体征原理学》， 1998年，第一版，中国医药科技出版社。
参编：《诊断学复习指南》， 2001年，第一版，山东科技出版社。
E-mail jiajun.l@163.com